An October 2026 report reveals a disconnect between menopause product messaging and consumer discussions about bloating and gas, highlighting evidence gaps.
On October 6, 2026, NutraIngredients published an industry report indicating that women’s menopause-related product discussions frequently include bloating, gas, and digestive urgency. The report, written by Afif Ghannoum, CEO of CPG Radar, highlights a gap between consumer symptoms and how brands typically position their products.
Historically, the scientific and medical community believed that menopause symptom management should strictly address hormonal fluctuations. Professionals viewed the physiological transition through a very narrow biological lens. The primary focus remained on well-known symptoms like hot flashes or sleep disturbances. Experts treated digestive function and the gut microbiome as entirely separate fields of medical study.
This separation meant that product developers rarely considered gastrointestinal comfort when designing support formulas. The consensus suggested that botanical ingredients only needed to target estrogen-related pathways to be effective. Formulators generally assumed that consumers would manage their digestive needs through unrelated dietary adjustments. A holistic view combining the gut-brain connection and whole-body wellness was notably absent from standard product development.
Furthermore, the industry operated under the assumption that familiar botanical extracts were universally tolerated. There was little push to investigate how these traditional ingredients might disrupt regular bowel habits. Brands built their marketing strategies around singular active components without accounting for the complete digestive experience. This narrow approach left a significant gap in understanding how complex biological systems interact.
As a result, consumers were often left navigating confusing bodily changes without adequate context. People experiencing shifting digestive patterns had few resources connecting their gut health to their broader life stage. The lack of integrated research meant that the daily realities of digestion were routinely minimized. This fragmented perspective shaped a market filled with products that ignored common gastrointestinal realities.
The recent report completely changes our understanding of what consumers are actually seeking. Ghannoum’s article argues that the menopause category currently suffers from a massive translation problem. Consumers are explicitly describing their practical symptoms and their desired avenues for relief. However, brands continue to lead their messaging with ingredient mechanisms rather than practical comfort.
The analysis found that product pages rarely mention the gastrointestinal issues that buyers frequently discuss. According to CPG Radar’s analysis, consumer conversation about menopause support dropped by half over the previous six months. Additionally, search volume for "menopause support" fell 30.1% during that exact same timeframe. Conversely, the report noted a striking 233% rise in conversation around "hormonal balance."
These behavioral shifts suggest that people are changing the language they use to describe their health. The industry must now recognize that traditional positioning may no longer resonate with public needs. The findings alter the current biological understanding of how products impact everyday life. A complete formulation must consider the actual experiences of the people consuming it.
The report also alters how we evaluate the substantiation behind common botanical ingredients. CPG Radar reports that black cohosh is currently present in more than 230 brands. However, the firm gave black cohosh an evidence score of 46, placing it squarely in an "emerging" tier. The report explicitly cites a score of 60-plus as the threshold that would match the ingredient's shelf prominence.
For a clearer comparison, the article notes an evidence score of 71 for inositol. The report states that inositol appears in 138 brands across the market. This discrepancy highlights a fundamental issue with how products are formulated and sold. The most popular ingredients do not necessarily hold the strongest levels of empirical support.
The article illustrates this real-world disconnect with an account from an unnamed consumer reviewer. This reviewer stated that sites recommending black cohosh for hot flashes had never warned her about potential bloating. Such accounts show how isolated symptom targeting can inadvertently trigger separate digestive discomforts. This new understanding shifts the focus toward comprehensive product transparency and better consumer education.
Consumer accounts regarding these products demonstrated an incredibly wide range of biological responses. The article says some users described finding symptom relief within a single week of use. Conversely, others reported experiencing no noticeable benefit after finishing a full 30-day supply. These varied outcomes emphasize that biological responses to supplements are highly individualized.
In response to these findings, the article proposes two potential industry adjustments. First, it suggests improving the substantiation of familiar ingredients by utilizing standardized extracts. Second, the article recommends exploring formulation combinations that include a gastrointestinal-focused ingredient. This combination strategy is proposed specifically to address the reported tolerability concerns.
These proposed changes mark a shift in how the industry views product design. Acknowledging the importance of gut health within broader wellness categories represents a significant step forward. This evolution aligns with a growing interest in the gut microbiome across various health sectors. However, these industry recommendations remain theoretical formulation strategies rather than proven medical treatments.
The new research carries several important constraints that readers must carefully consider. The evidence scores for black cohosh and inositol are proprietary CPG Radar metrics. These numbers are not recognized clinical trial results or universal scientific standards. The article completely omits any explanation of the scoring formula used to generate these specific figures.
Furthermore, the underlying data relies heavily on search behavior and unverified consumer reviews. The report does not disclose the sample sizes or the geographic scope of its extensive analysis. The exact comparison dates and demographic breakdowns are also missing from the public summary. These limitations mean the findings serve as market signals rather than definitive health statistics.
It is also crucial to note that the consumer accounts do not represent controlled clinical outcomes. The article does not identify the specific products that generated the varied user experiences. The proposed combination of a familiar botanical with a gastrointestinal-focused ingredient is merely a formulation opportunity. The report supplies absolutely no clinical results proving that this proposed pairing resolves digestive distress.
Broader industry coverage reinforces the need for careful interpretation of product claims. NutraIngredients recently reported on a Which? review covering 26 popular perimenopause and menopause supplements. Separately, researchers from UCL reviewed a staggering 201 products within this specific category. The UCL review found substantial variation in both costs and ingredients across the analyzed market.
Crucially, the UCL researchers described the empirical evidence for these symptom-reduction products as highly limited. The products evaluated in these reports represent only a fraction of the available options. The available coverage does not establish that any specific product clinically relieves the digestive symptoms discussed. The mere presence of an ingredient does not guarantee a reliable or measurable health outcome.
These reviews highlight the exact constraints that complicate everyday health decisions. A high product count or a premium price tag does not substitute for empirical evidence. The lack of standardized formulations means that consumers face significant hurdles when evaluating their options. These constraints emphasize the importance of looking beyond marketing claims when assessing any supplement.
Another significant limitation of this new research involves the interpretation of online search patterns. The reported drops in specific keyword searches cannot be directly translated into a lack of biological need. While consumer conversation about targeted support dropped by half, this does not mean the underlying physical symptoms disappeared. The article interprets these specific figures as a simple change in consumer language.
However, the public description of this proprietary report does not provide the contextual data necessary to establish why those changes occurred. A shift toward broader terminology might simply reflect changing digital trends rather than genuine medical shifts. Without controlled longitudinal studies, these behavioral metrics only capture a small snapshot of public attention. Relying on search volume to guide nutritional decisions remains an inherently flawed strategy for long-term wellness.
This industry news realistically means that consumers must evaluate dietary choices and product claims with increased caution. An ingredient’s simple presence on a label does not prove that a finished product will provide digestive comfort. Shoppers should actively look for clear information regarding intended use, ingredient form, and appropriate dosages. The evidence supporting the complete finished product matters far more than isolated marketing terms.
These market analyses do not establish that every episode of bloating or urgency is inherently menopause-related. Individuals should continue focusing on balanced nutrition and healthy dietary habits rather than relying on supplements. Understanding everyday gut function requires recognizing the biological limits of current product formulations. Consistent dietary choices offer a more reliable foundation for wellness than speculative botanical blends.
By prioritizing established evidence over proprietary scores, consumers can make informed choices that support long-term wellbeing. Evaluating products carefully helps individuals separate genuine nutritional support from exaggerated industry trends. Anyone experiencing persistent digestive changes should consult a qualified healthcare professional for personalized guidance. True digestive health relies on objective analysis, clear context, and a realistic understanding of human biology.
For adults managing their own nutritional choices day to day, analyzing complex symptom patterns requires an objective scientific perspective. DigestGenius resolves the difficulty understanding bloating, regularity and other everyday digestive patterns by offering our Educational Content Platform (flagship). This service delivers free educational articles and in-depth resources about digestion, microbiome science, nutrition and digestive wellness. Explore the Blog
DigestGenius publishes research-led guidance on digestion, the gut microbiome, fiber, probiotics, gut-brain signaling, inflammation and everyday digestive wellbeing.
Explore clear, research-led guidance on digestion, the microbiome, food, fiber, probiotics and the gut-brain connection.
read the blog
